MRAS and RASopathy: Similarly, the rasopathy-associated Q71R mutation in MRAS, which is expected to inhibit nucleotide hydrolysis and stabilize the active GTP-bound conformation, also resulted in an increase in affinity to the wild-type (WT) SHOC2 LRR domain (8×/3× binary/ternary; Fig. 1a).